Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration

被引:84
|
作者
Chakravarthy, Usha [1 ,2 ]
Goldenberg, Dafna [3 ,4 ]
Young, Graham [2 ]
Havilio, Moshe [5 ]
Rafaeli, Omer [5 ]
Benyamini, Gidi [5 ]
Loewenstein, Anat [3 ,4 ]
机构
[1] Queens Univ Belfast, Ctr Expt Med Dent & Biomed Sci, Belfast BT12 6BA, Antrim, North Ireland
[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[3] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Notal Vis Ltd, Tel Aviv, Israel
关键词
OPTICAL COHERENCE TOMOGRAPHY; VISUAL-ACUITY; RANIBIZUMAB; SEGMENTATION; BEVACIZUMAB; IMAGES;
D O I
10.1016/j.ophtha.2016.04.005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The objective of the study was to evaluate the accuracy of the Notal OCT Analyzer (NOA) versus that of a retina specialist (RS) in the automated detection of fluid on optical coherence tomography (OCT). Design: A study of the performance of the NOA compared with the results from 3 RSs. Participants: A selection of 155 anonymized OCT scans (Zeiss Cirrus; Carl Zeiss Meditec, Dublin, CA) from an image repository at a single tertiary referral retina center (Belfast Health and Social Care Trust, Belfast, United Kingdom) after approval from the local data guardian of the clinical site. Methods: One hundred fifty-five OCT cube scans were stripped of all clinical identifiers and exported. The NOA and 3 independent RSs analyzed all 128 B-scans of each cube scan for the presence of intraretinal fluid, subretinal fluid, and suberetinal pigment epithelium fluid. The NOA also ranked individual B-scans of each volume scan for likelihood of CNV activity, which was subjected to a second grading session by the 3 RSs. Main Outcome Measures: The NOA's sensitivity and specificity versus the RS grading and the NOA's performance in ranking B-scans for activity. Results: One hundred forty-two cube scans met the inclusion criteria for the primary analysis. On testing the RS grading versus the NOA, the accuracy was 91% (95% confidence interval [CI], +/- 7%), sensitivity was 92% (95% CI, +/- 6%), and specificity was 91% (95% CI, +/- 6%), meeting the primary outcome. The graders' accuracy when compared with the majority of the other graders (including a fourth grader) was 93%. On average, the 3 graders could identify fluid in 95% of scans by just reviewing a single cross-section with the highest NOA score and 99.5% of scans with fluid by viewing the top 3 cross-sections. Conclusions: Concordance between the NOA and the RS determination of lesion activity was extremely high. The level of discrepancy between the RS and the NOA results was similar to the NOA's mismatches. Our results show that automated delineation of the retinal contours combined with interpretation of disease activity is feasible and has the potential to become a powerful tool in terms of its clinical applications. (C) 2016 by the American Academy of Ophthalmology.
引用
收藏
页码:1731 / 1736
页数:6
相关论文
共 50 条
  • [41] Six-year outcomes in neovascular age-related macular degeneration with ranibizumab
    Julie Jacob
    Heidi Brié
    Anita Leys
    Laurent Levecq
    Filip Mergaerts
    Kris Denhaerynck
    Stefaan Vancayzeele
    Eline Van Craeyveld
    Ivo Abraham
    Karen Mac Donald
    International Journal of Ophthalmology, 2017, 10 (01) : 81 - 90
  • [42] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [43] Deep Learning in Neovascular Age-Related Macular Degeneration
    Borrelli, Enrico
    Serafino, Sonia
    Ricardi, Federico
    Coletto, Andrea
    Neri, Giovanni
    Olivieri, Chiara
    Ulla, Lorena
    Foti, Claudio
    Marolo, Paola
    Toro, Mario Damiano
    Bandello, Francesco
    Reibaldi, Michele
    MEDICINA-LITHUANIA, 2024, 60 (06):
  • [44] Abicipar pegol for neovascular age-related macular degeneration
    Hussain, Rehan M.
    Weng, Christina Y.
    Wykoff, Charles C.
    Gandhi, Raya A.
    Hariprasad, Seenu M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (09) : 999 - 1007
  • [45] Review of Fibrosis in Neovascular Age-Related Macular Degeneration
    Cheong, Kai Xiong
    Cheung, Chui Ming Gemmy
    Teo, Kelvin Yi Chong
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 246 : 192 - 222
  • [46] Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration
    Jackson, Timothy L.
    Chakravarthy, Usha
    Slakter, Jason S.
    Muldrew, Alyson
    Shusterman, E. Mark
    O'Shaughnessy, Denis
    Arnoldussen, Mark
    Gertner, Michael E.
    Danielson, Linda
    Moshfeghi, Darius M.
    OPHTHALMOLOGY, 2015, 122 (01) : 138 - 145
  • [47] Choroidal thickness and visual prognosis in type 1 lesion due to neovascular age-related macular degeneration
    Hernandez-Martinez, Pablo
    Dolz-Marco, Rosa
    Hervas-Marin, David
    Andreu-Fenoll, Maria
    Gallego-Pinazo, Roberto
    Arevalo, Jose Fernando
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : 196 - 200
  • [48] The nature and frequency of neovascular age-related macular degeneration
    Iranmanesh, R.
    Eandi, C. M.
    Peiretti, E.
    Klais, C. M.
    Garuti, S.
    Goldberg, D. E.
    Slakter, J. S.
    Yannuzzi, L. A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (01) : 75 - 83
  • [49] Vitreomacular Adhesion and Neovascular Age-Related Macular Degeneration
    Simpson, Andrew R. H.
    Petrarca, Robert
    Jackson, Timothy L.
    SURVEY OF OPHTHALMOLOGY, 2012, 57 (06) : 498 - 509
  • [50] Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
    K. Bailey Freund
    Giovanni Staurenghi
    Jesse J. Jung
    Sandrine A. Zweifel
    Mariano Cozzi
    Lauren Hill
    Steven Blotner
    Min Tsuboi
    Shamika Gune
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2437 - 2447